Pre-earnings brief
Reports
Thu, Nov 5, 2026
Est. EPS
—
Est. revenue
—
Implied move
±13.4%
EPS beat rate
75%
The Chemours Company (CC) operates in the materials sector, focusing on diversified chemicals. It plays a crucial role in supplying essential materials for various industries, which are influenced by trends in sustainability and environmental regulations.
Last quarter
In Q2-2026, Chemours reported an EPS of $0.42, slightly missing the estimate of $0.43. The stock reacted positively, gaining 4.79% the following day.
EPS beat streak
0Q
EPS beat rate
75%
Avg EPS surprise
+334.83%
Avg 1-day reaction
+3.02%
Analysts are uncertain about Chemours' upcoming earnings, especially given the lack of analyst estimates and management guidance.
Bull case
If Chemours can exceed expectations on EPS and show strong revenue growth, it could signal a recovery and boost investor confidence.
Bear case
Conversely, if the company reports disappointing results or provides weak guidance, it could lead to a significant drop in stock price.
The print will turn on these.
Q1
What will the EPS be for Q3-2026?
EPS is a critical measure of profitability and will heavily influence investor sentiment.
Q2
How does Chemours plan to address any challenges in revenue growth?
Understanding the company's strategy for growth will be essential for assessing its future performance.
Est. EPS
$1.98
Est. Rev
$113.6B
Impl. Move
±6.9%
Why consensus could be wrong
The Street may be underestimating Chemours' ability to leverage recent product innovations, which could drive unexpected revenue growth.
Supporting evidence
The options market is pricing a larger move than historical averages, indicating potential for a surprise.
Chemours has a strong track record of beating EPS estimates, suggesting it could outperform again.
Key risk
If the EPS exceeds $0.45, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is debating whether Chemours can maintain profitability and grow revenue amidst industry challenges.
Bull confirmed if
An EPS of $0.45 or higher would confirm the bull case, indicating strong profitability.
Bear confirmed if
An EPS below $0.35 would confirm the bear case, suggesting ongoing challenges.
What the market is pricing for the move.
Implied Move
±13.35%
Historical Avg
±4.5%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.
Options are pricing ±13.4% while CC has averaged ±4.5% over the last 8 prints — setup is pricing rich.
ATM IV
0.6%
30d HV
29.3%
Smart-money positioning from the most recent 13F filings.
Institutional
91.38%
of float
Insider
0.37%
of float
Holders
615
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
23,283,074 sh · $325.5M
15.47%
4.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Chemours beats expectations, history suggests a potential stock increase of around +3.23%, confirming a positive outlook.
In line / cautious
If results are in line but cautious, the stock may see minimal movement as investors digest the commentary.
Miss
A miss could lead to a decline of about -2.40%, reflecting disappointment in performance.
The lines on the call that would change the story.
Vanguard Portfolio Management LLC
10,568,867 sh · $147.8M
7.02%
2.4%
Vanguard Capital Management LLC
6,784,588 sh · $94.8M
4.51%
0.2%
State Street Corporation
6,115,375 sh · $85.5M
4.06%
-0.1%
Ameriprise Financial, Inc.
4,924,004 sh · $68.8M
3.27%
1.8%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.